Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Diabetes|March 5, 2008
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitisLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
The Journal of Nutrition|July 3, 2015
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or ObesityAlison Mondul, Rosellina M Mancina, Andrea Merlo, et al.
World Journal of Gastroenterology|June 22, 2012
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosisLuca Valenti, Paolo Maggioni, Alberto Piperno, et al.
Journal of Hepatology|August 14, 2012
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosisLuca Valenti, Anna Ludovica Fracanzani, Raffaela Rametta, et al.
European Journal of Clinical Investigation|May 16, 2014
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistanceRaffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, et al.
Journal of Hepatology|September 25, 2012
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosisLuca Valenti, Paola Dongiovanni, Marco Maggioni, et al.
World Journal of Gastroenterology|March 25, 2014
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemiaLuca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, et al.
Nature Communications|March 24, 2021
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liverKyeongJin Kim, Jin Ku Kang, Young Hoon Jung, et al.
Plos One|November 13, 2012
The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver diseaseLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
Pageof 6